Dec. 22, 2021
What happened couple days ago with Intra-Cellular Therapies (ITCI)?
Lead drug (Caplyta) gained FDA approval to treat bipolar depression.
Consequently, the stock rallied by 15%.
Now, what if you have the skills to forecast such FDA approval?
No comments:
Post a Comment